A

AZ Sint-Lucas | Center for Clinical Studies

Research site
(Unclaimed)
Location
Molenaarsstraat 111, Gent, East Flanders, Belgium
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

14 of 34
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS) is a common chronic gastrointestinal condition that affects approximately 10-20% of adults in Western countries. IBS i...

Enrolling
Irritable Bowel Syndrome
Other: DDDI-IBS-001 placebo
Dietary Supplement: DDI-IBS-001

This trial is an extension of the antecedent trial ARGX-117-2002. It is a multicenter trial that has been designed to evaluate the long-term safety a...

Enrolling
Multifocal Motor Neuropathy (MMN)
Biological: ARGX-117
Other: Placebo

A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered...

Active, not recruiting
Crohn's Disease
Drug: Upadacitinib
Drug: Placebo for Upadacitinib

This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adu...

Enrolling
Crohn's Disease
Drug: Etrasimod
Drug: Placebo

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severe...

Enrolling
Colitis, Ulcerative
Drug: JNJ-77242113
Drug: Placebo

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Other: Placebo
Drug: Milvexian

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravi...

Enrolling
Myasthenia Gravis
Drug: Placebo
Drug: Nipocalimab

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Locations recently updated

The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Enrolling
Prurigo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

The primary objective is:To evaluate the effect of pozelimab + cemdisiran on daily functioning that is impacted by signs and symptoms in patients wit...

Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab + Cemdisiran
Drug: Pozelimab

This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as mainten...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: ABX464

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinica...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: ABX464

The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for moderately active ulcerative colitis in adult...

Active, not recruiting
Ulcerative Colitis
Drug: Placebo
Drug: Etrasimod

This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen e...

Invitation-only
Acute Myocardial Infarction
Combination Product: Placebo
Combination Product: Selatogrel

Trial conditions

Colitis (7 trials)
Ulcer (7 trials)
Ulcerative Colitis (7 trials)
Crohn Disease (5 trials)
COVID-19 (3 trials)
Muscle Weakness (2 trials)
Myasthenia Gravis (2 trials)
Syndrome (2 trials)
Acute Coronary Syndrome (1 trial)
Arteriovenous Malformati... (1 trial)

And 29 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems